{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:07Z","timestamp":1786991227349,"version":"build-2736575974"},"reference-count":150,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,3]],"date-time":"2027-07-03T00:00:00Z","timestamp":1814572800000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaci.2026.04.013","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:15:09Z","timestamp":1777454109000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Group 2 innate lymphoid cells: Where are we 15 years out?"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3256-0398","authenticated-orcid":false,"given":"Taylor A.","family":"Doherty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.04.013_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.04.013_bib2","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nature08900","article-title":"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity","volume":"464","author":"Neill","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.04.013_bib3","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1073\/pnas.1003988107","article-title":"Systemically dispersed innate IL-13-expressing cells in type 2 immunity","volume":"107","author":"Price","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.04.013_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells--a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib5","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","article-title":"IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo","volume":"15","author":"Fort","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.013_bib6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mjosberg","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib7","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.jaci.2021.03.015","article-title":"Roles of innate lymphoid cells (ILCs) in allergic diseases: the 10-year anniversary for ILC2s","volume":"147","author":"Bartemes","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2026.04.013_bib9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jaci.2020.01.038","article-title":"Optimal identification of human conventional and nonconventional (CRTH2(-)IL7Ralpha(-)) ILC2s using additional surface markers","volume":"146","author":"Liu","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib10","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jaci.2019.07.018","article-title":"Unconventional ST2- and CD127-negative lung ILC2 populations are induced by the fungal allergen Alternaria alternata","volume":"144","author":"Cavagnero","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib11","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41577-022-00704-5","article-title":"Heterogeneity of type 2 innate lymphoid cells","volume":"22","author":"Spits","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.immuni.2021.05.007","article-title":"GPR34-mediated sensing of lysophosphatidylserine released by apoptotic neutrophils activates type 3 innate lymphoid cells to mediate tissue repair","volume":"54","author":"Wang","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.013_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70036","article-title":"ILC2 diversity, location, and function in pulmonary disease","volume":"332","author":"Verma","year":"2025","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2026.04.013_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2024.102503","article-title":"Metabolic adaptations of ILC2 and Th2 cells in type 2 immunity","volume":"91","author":"Kania","year":"2024","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/imr.13323","article-title":"New insights into ILC2 memory","volume":"323","author":"Martinez-Gonzalez","year":"2024","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2026.04.013_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.alit.2022.12.001","article-title":"Group 2 innate lymphoid cells in human asthma","volume":"72","author":"Iwata","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2026.04.013_bib17","first-page":"85","article-title":"Modulating ILC2 function for treatment of type 2 airway diseases","volume":"23","author":"Huang","year":"2022","journal-title":"Curr Trends Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib18","article-title":"Neural regulation of ILC2s in allergic airway inflammation","volume":"3","author":"Thomas","year":"2022","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaci.2026.04.013_bib19","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2025.01.017","article-title":"Targeting alarmins in asthma: from bench to clinic","volume":"155","author":"Akenroye","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib20","article-title":"Regulation of the tuft cell-ILC2 circuit in intestinal mucosal immunity","volume":"16","author":"Shang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/all.70030","article-title":"The expanding role of ILC2s in allergic airways disease","volume":"81","author":"Cain","year":"2026","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.04.013_bib22","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/s12276-023-01021-0","article-title":"The modulation of pulmonary group 2 innate lymphoid cell function in asthma: from inflammatory mediators to environmental and metabolic factors","volume":"55","author":"Thio","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.it.2022.09.006","article-title":"Neuro-epithelial-ILC2 crosstalk in barrier tissues","volume":"43","author":"Yin","year":"2022","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature23469","article-title":"Neuronal regulation of type 2 innate lymphoid cells via neuromedin U","volume":"549","author":"Cardoso","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.04.013_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature24029","article-title":"The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation","volume":"549","author":"Wallrapp","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.04.013_bib26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature23676","article-title":"The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation","volume":"549","author":"Klose","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.04.013_bib27","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41590-020-0753-y","article-title":"Basophils prime group 2 innate lymphoid cells for neuropeptide-mediated inhibition","volume":"21","author":"Inclan-Rico","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib28","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.aan4829","article-title":"Beta2-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses","volume":"359","author":"Moriyama","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jaci.2026.04.013_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/science.adi3624","article-title":"Neuronal-ILC2 interactions regulate pancreatic glucagon and glucose homeostasis","volume":"387","author":"Sestan","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.jaci.2026.04.013_bib30","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/all.16536","article-title":"Dopamine as a potential modulator of ILC2-driven lung inflammation via mitochondrial regulation","volume":"80","author":"Silva","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.04.013_bib31","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.immuni.2023.03.019","article-title":"Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activity","volume":"56","author":"Cao","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.013_bib32","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41423-023-00982-6","article-title":"HTR2A agonists play a therapeutic role by restricting ILC2 activation in papain-induced lung inflammation","volume":"20","author":"Wang","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41385-021-00475-7","article-title":"Adenosine restrains ILC2-driven allergic airway inflammation via A2A receptor","volume":"15","author":"Xiao","year":"2022","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe3218","article-title":"The ChAT-acetylcholine pathway promotes group 2 innate lymphoid cell responses and anti-helminth immunity","volume":"6","author":"Chu","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd0359","article-title":"Acetylcholine production by group 2 innate lymphoid cells promotes mucosal immunity to helminths","volume":"6","author":"Roberts","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13202","article-title":"Nicotinic acetylcholine receptor agonist attenuates ILC2-dependent airway hyperreactivity","volume":"7","author":"Galle-Treger","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.04.013_bib37","doi-asserted-by":"crossref","first-page":"22043","DOI":"10.1074\/jbc.M116.743187","article-title":"Leptin enhances TH2 and ILC2 responses in allergic airway disease","volume":"291","author":"Zheng","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2026.04.013_bib38","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191054","article-title":"Adiponectin restrains ILC2 activation by AMPK-mediated feedback inhibition of IL-33 signaling","volume":"218","author":"Wang","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib39","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1111\/all.14879","article-title":"Glucagon-like peptide-1 receptor agonist inhibits aeroallergen-induced activation of ILC2 and neutrophilic airway inflammation in obese mice","volume":"76","author":"Toki","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.04.013_bib40","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jaci.2017.11.043","article-title":"Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo","volume":"142","author":"Toki","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaci.2026.04.013_bib42","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jaip.2025.04.055","article-title":"Diagnosis and treatment options for T2-low asthma","volume":"13","author":"Thomas","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.04.013_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan8546","article-title":"Pulmonary neuroendocrine cells amplify allergic asthma responses","volume":"360","author":"Sui","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jaci.2026.04.013_bib44","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.immuni.2019.06.009","article-title":"Neuropeptide CGRP limits group 2 innate lymphoid cell responses and constrains type 2 inflammation","volume":"51","author":"Nagashima","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.013_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cell.2023.11.027","article-title":"Sensory neurons promote immune homeostasis in the lung","volume":"187","author":"Tamari","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2026.04.013_bib46","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.immuni.2019.09.004","article-title":"Transcriptional atlas of intestinal immune cells reveals that neuropeptide alpha-CGRP modulates group 2 innate lymphoid cell responses","volume":"51","author":"Xu","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.013_bib47","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.immuni.2025.01.004","article-title":"Bi-directional communication between intrinsic enteric neurons and ILC2s inhibits host defense against helminth infection","volume":"58","author":"Wang","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.013_bib48","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/s41590-025-02243-2","article-title":"CGRP-related neuropeptide adrenomedullin 2 promotes tissue-protective ILC2 responses and limits intestinal inflammation","volume":"26","author":"Uddin","year":"2025","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib49","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3389\/fimmu.2017.01069","article-title":"Sex differences in asthma: a key role of androgen-signaling in group 2 innate lymphoid cells","volume":"8","author":"Laffont","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib50","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1084\/jem.20161807","article-title":"Androgen signaling negatively controls group 2 innate lymphoid cells","volume":"214","author":"Laffont","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4049\/jimmunol.1602085","article-title":"IL-33-responsive group 2 innate lymphoid cells are regulated by female sex hormones in the uterus","volume":"200","author":"Bartemes","year":"2018","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib52","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1016\/j.celrep.2017.10.110","article-title":"Testosterone attenuates group 2 innate lymphoid cell-mediated airway inflammation","volume":"21","author":"Cephus","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2026.04.013_bib53","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/all.14491","article-title":"Estrogen receptor-alpha signaling increases allergen-induced IL-33 release and airway inflammation","volume":"76","author":"Cephus","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.04.013_bib54","article-title":"Circadian-clock-controlled endocrine and cytokine signals regulate multipotential innate lymphoid cell progenitors in the bone marrow","volume":"43","author":"Liu","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2026.04.013_bib55","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03830-7","article-title":"Neuro-mesenchymal units control ILC2 and obesity via a brain-adipose circuit","volume":"597","author":"Cardoso","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.04.013_bib56","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211001","article-title":"Angiotensin II enhances group 2 innate lymphoid cell responses via AT1a during airway inflammation","volume":"219","author":"Liu","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib57","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jaci.2021.09.037","article-title":"Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity","volume":"149","author":"Hurrell","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib58","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211985","article-title":"Hypoxia induces adrenomedullin from lung epithelia, stimulating ILC2 inflammation and immunity","volume":"219","author":"Han","year":"2022","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib59","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-065X.2007.00512.x","article-title":"Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation","volume":"217","author":"Boyce","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2026.04.013_bib60","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.anai.2020.09.011","article-title":"Lipid-mediated innate lymphoid cell recruitment and activation in aspirin-exacerbated respiratory disease","volume":"126","author":"Cavagnero","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib61","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jaci.2018.02.034","article-title":"Lipid regulation of group 2 innate lymphoid cell function: moving beyond epithelial cytokines","volume":"141","author":"Doherty","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaci.2013.03.048","article-title":"Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production","volume":"132","author":"Doherty","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib63","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaci.2016.12.958","article-title":"Cysteinyl leukotriene E(4) activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D(2) and epithelial cytokines","volume":"140","author":"Salimi","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib64","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jaci.2013.09.020","article-title":"Prostaglandin D2 regulates human type 2 innate lymphoid cell chemotaxis","volume":"133","author":"Chang","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1164\/rccm.201410-1793OC","article-title":"Prostaglandin I2 signaling and inhibition of group 2 innate lymphoid cell responses","volume":"193","author":"Zhou","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib66","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.jaci.2017.09.050","article-title":"Prostaglandin E2 suppresses human group 2 innate lymphoid cell function","volume":"141","author":"Maric","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3389\/fimmu.2018.00501","article-title":"Prostaglandin E2 inhibits group 2 innate lymphoid cell activation and allergic airway inflammation through E-prostanoid 4-cyclic adenosine monophosphate signaling","volume":"9","author":"Zhou","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib68","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/jimmun\/vkaf088","article-title":"PGI2 restricts trained ILC2 responses in allergic inflammation","volume":"214","author":"Zhou","year":"2025","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib69","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ni.3444","article-title":"IL-1beta, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs","volume":"17","author":"Bal","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib70","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ni.3447","article-title":"IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity","volume":"17","author":"Ohne","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib71","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/ni.3443","article-title":"Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs","volume":"17","author":"Silver","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib72","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41590-018-0201-4","article-title":"Tissue signals imprint ILC2 identity with anticipatory function","volume":"19","author":"Ricardo-Gonzalez","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib73","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni.3078","article-title":"IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells","volume":"16","author":"Huang","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib74","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1038\/s41467-019-09883-7","article-title":"IL-1beta, IL-23, and TGF-beta drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation","volume":"10","author":"Golebski","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.04.013_bib75","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaci.2018.03.007","article-title":"IL-17-producing ST2(+) group 2 innate lymphoid cells play a pathogenic role in lung inflammation","volume":"143","author":"Cai","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib76","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.4049\/jimmunol.1601421","article-title":"Cutting edge: Notch signaling promotes the plasticity of group-2 innate lymphoid cells","volume":"198","author":"Zhang","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib77","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1038\/s41467-022-32176-5","article-title":"RNA-binding protein RBM3 intrinsically suppresses lung innate lymphoid cell activation and inflammation partially through CysLT1R","volume":"13","author":"Badrani","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.04.013_bib78","doi-asserted-by":"crossref","first-page":"eado6649","DOI":"10.1126\/scitranslmed.ado6649","article-title":"A population of c-kit(+) IL-17A(+) ILC2s in sputum from individuals with severe asthma supports ILC2 to ILC3 trans-differentiation","volume":"17","author":"Ju","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202149435","article-title":"ILC1: development, maturation, and transcriptional regulation","volume":"53","author":"Taggenbrock","year":"2023","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib80","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41422-020-00445-x","article-title":"Tissue-specific transcriptional imprinting and heterogeneity in human innate lymphoid cells revealed by full-length single-cell RNA-sequencing","volume":"31","author":"Mazzurana","year":"2021","journal-title":"Cell Res"},{"key":"10.1016\/j.jaci.2026.04.013_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd3489","article-title":"Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases","volume":"6","author":"van der Ploeg","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib82","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41420-024-02096-y","article-title":"Tissue microenvironment induces tissue specificity of ILC2","volume":"10","author":"Qin","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.jaci.2026.04.013_bib83","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.it.2020.08.009","article-title":"Tissue-specific features of innate lymphoid cells","volume":"41","author":"Meininger","year":"2020","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib84","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MCP.0000000000000342","article-title":"T2-low asthma: current approach to diagnosis and therapy","volume":"23","author":"Samitas","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib85","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41467-017-02023-z","article-title":"Alternative activation generates IL-10 producing type 2 innate lymphoid cells","volume":"8","author":"Seehus","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.04.013_bib86","doi-asserted-by":"crossref","DOI":"10.1172\/JCI193134","article-title":"ICOS regulates IL-10 production in group 2 innate lymphoid cells via cholesterol and cortisol biosynthesis","volume":"135","author":"Sakano","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.04.013_bib87","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41467-025-67813-2","article-title":"Genetic diversity of Collaborative Cross mice implicates FFAR3 as a target for ILC2 anti-inflammatory reprogramming","volume":"17","author":"Rusznak","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.04.013_bib88","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.immuni.2020.12.013","article-title":"Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response","volume":"54","author":"Golebski","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.013_bib89","article-title":"STAT6 and lung inflammation","volume":"2","author":"Walford","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.jaci.2026.04.013_bib90","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/mi.2016.4","article-title":"IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection","volume":"9","author":"Pelly","year":"2016","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib91","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ni.3294","article-title":"Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses","volume":"17","author":"Halim","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib92","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41586-024-07746-w","article-title":"ILC2-derived LIF licences progress from tissue to systemic immunity","volume":"632","author":"Gogoi","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.04.013_bib93","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.immuni.2018.05.003","article-title":"Tissue-restricted adaptive type 2 immunity is orchestrated by expression of the costimulatory molecule OX40L on group 2 innate lymphoid cells","volume":"48","author":"Halim","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.013_bib94","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adl1903","article-title":"Cross-talk between ILC2 and Gata3(high) T(regs) locally constrains adaptive type 2 immunity","volume":"9","author":"Stockis","year":"2024","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib95","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1165\/rcmb.2025-0299OC","article-title":"Targeting CD48 ameliorates ILC2-mediated airway hyperreactivity by disrupting the PKCbeta pathway","volume":"74","author":"Sakano","year":"2026","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2026.04.013_bib96","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1038\/s41467-020-17813-1","article-title":"PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity","volume":"11","author":"Helou","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.04.013_bib97","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1164\/rccm.201909-1722OC","article-title":"The role of the TL1A\/DR3 axis in the activation of group 2 innate lymphoid cells in subjects with eosinophilic asthma","volume":"202","author":"Machida","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib98","doi-asserted-by":"crossref","first-page":"L577","DOI":"10.1152\/ajplung.00174.2012","article-title":"STAT6 regulates natural helper cell proliferation during lung inflammation initiated by Alternaria","volume":"303","author":"Doherty","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jaci.2026.04.013_bib99","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.1102832","article-title":"IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs","volume":"188","author":"Bartemes","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.immuni.2012.06.012","article-title":"Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation","volume":"37","author":"Halim Timotheus","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.013_bib101","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.immuni.2012.06.012","article-title":"Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation","volume":"37","author":"Halim","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.013_bib102","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaci.2014.02.033","article-title":"Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures","volume":"133","author":"Gold","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib103","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2014.01.011","article-title":"Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation","volume":"40","author":"Halim","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.013_bib104","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41586-022-05395-5","article-title":"Non-redundant functions of group 2 innate lymphoid cells","volume":"611","author":"Jarick","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.04.013_bib105","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.ade4177","article-title":"Neuromedin U programs eosinophils to promote mucosal immunity of the small intestine","volume":"381","author":"Li","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jaci.2026.04.013_bib106","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl0370","article-title":"Mef2d potentiates type-2 immune responses and allergic lung inflammation","volume":"384","author":"Szeto","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.jaci.2026.04.013_bib107","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/eji.201747388","article-title":"Mouse models for the study of fate and function of innate lymphoid cells","volume":"48","author":"Cording","year":"2018","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib108","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20250883","article-title":"Emerging in vivo tools for ILC2 research","volume":"222","author":"Halim","year":"2025","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib109","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.immuni.2016.06.017","article-title":"Allergen-experienced group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation","volume":"45","author":"Martinez-Gonzalez","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.013_bib110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135961","article-title":"Lung group 2 innate lymphoid cells are trained by endogenous IL-33 in the neonatal period","volume":"5","author":"Steer","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2026.04.013_bib111","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1016\/j.cell.2025.08.017","article-title":"IL-25-induced memory type 2 innate lymphoid cells enforce mucosal immunity","volume":"188","author":"Cortez","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2026.04.013_bib112","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2025.08.029","article-title":"Brg1-imprinted chromatin status controls effector and memory group 2 innate lymphoid cell metabolism to exacerbate allergic lung inflammation","volume":"157","author":"Tang","year":"2026","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib113","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1038\/s41467-025-62532-0","article-title":"TLR4(+)group 2 innate lymphoid cells contribute to persistent type 2 immunity in airway diseases","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.04.013_bib114","doi-asserted-by":"crossref","first-page":"7850","DOI":"10.1038\/s41467-024-52252-2","article-title":"TCF-1 and TOX regulate the memory formation of intestinal group 2 innate lymphoid cells in asthma","volume":"15","author":"Bao","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2026.04.013_bib115","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109300","article-title":"c-Maf enforces cytokine production and promotes memory-like responses in mouse and human type 2 innate lymphoid cells","volume":"41","author":"Trabanelli","year":"2022","journal-title":"EMBO J"},{"key":"10.1016\/j.jaci.2026.04.013_bib116","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201354","article-title":"The molecular and epigenetic mechanisms of innate lymphoid cell (ILC) memory and its relevance for asthma","volume":"218","author":"Verma","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib117","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.immuni.2025.07.022","article-title":"Transcription factor BACH2 shapes tissue-resident memory T cell programs to promote HIV-1 persistence","volume":"58","author":"Wei","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.013_bib118","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231827","article-title":"Human CD127 negative ILC2s show immunological memory","volume":"221","author":"Matha","year":"2024","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib119","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.it.2019.10.007","article-title":"Exhausted-like group 2 innate lymphoid cells in chronic allergic inflammation","volume":"40","author":"Ebihara","year":"2019","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib120","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jaci.2014.06.024","article-title":"Enhanced innate type 2 immune response in peripheral blood from patients with asthma","volume":"134","author":"Bartemes","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib121","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaci.2015.05.037","article-title":"Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia","volume":"137","author":"Smith","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib122","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaci.2015.06.038","article-title":"Type 2 innate lymphoid cells in induced sputum from children with severe asthma","volume":"137","author":"Nagakumar","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib123","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000488050","article-title":"Increased group 2 innate lymphoid cells are correlated with eosinophilic granulocytes in patients with allergic airway inflammation","volume":"176","author":"Yu","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib124","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jaci.2019.01.027","article-title":"Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patients","volume":"144","author":"Winkler","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib125","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1164\/rccm.201612-2427OC","article-title":"Allergen-induced increases in sputum levels of group 2 innate lymphoid cells in asthmatic subjects","volume":"196","author":"Chen","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib126","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jaci.2017.12.1006","article-title":"Epigenome analysis links gene regulatory elements in group 2 innate lymphocytes to asthma susceptibility","volume":"142","author":"Stadhouders","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib127","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/all.13438","article-title":"ILC2 frequency and activity are inhibited by glucocorticoid treatment via STAT pathway in patients with asthma","volume":"73","author":"Yu","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.04.013_bib128","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaci.2017.03.032","article-title":"Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin","volume":"141","author":"Liu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib129","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi3770","article-title":"JAK3 inhibitor suppresses multipotent ILC2s and attenuates steroid-resistant asthma","volume":"9","author":"Kim","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.jaci.2026.04.013_bib130","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1111\/all.16633","article-title":"High-dimensional analysis of type 2 lymphocyte dynamics during mepolizumab or dupilumab treatment in severe asthma","volume":"80","author":"Wirth","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.04.013_bib131","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/resp.14506","article-title":"Severe asthma ILC2s demonstrate enhanced proliferation that is modified by biologics","volume":"28","author":"Malik","year":"2023","journal-title":"Respirology"},{"key":"10.1016\/j.jaci.2026.04.013_bib132","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2016.11.023","article-title":"Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease","volume":"140","author":"Eastman","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib133","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clim.2014.09.007","article-title":"Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness","volume":"155","author":"Walford","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib134","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/iid3.161","article-title":"Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps","volume":"5","author":"Poposki","year":"2017","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jaci.2026.04.013_bib135","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4049\/jimmunol.1601569","article-title":"Leukotriene C4 potentiates IL-33-induced group 2 innate lymphoid cell activation and lung inflammation","volume":"199","author":"Lund","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib136","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41385-019-0215-8","article-title":"Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps","volume":"13","author":"Ogasawara","year":"2020","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib137","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1056\/NEJMra1712125","article-title":"Aspirin-exacerbated respiratory disease","volume":"379","author":"White","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib138","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaci.2021.06.016","article-title":"Innate immune cell dysregulation drives inflammation and disease in aspirin-exacerbated respiratory disease","volume":"148","author":"Eid","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib139","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaip.2016.11.021","article-title":"Plasma 15-hydroxyeicosatetraenoic acid predicts treatment outcomes in aspirin-exacerbated respiratory disease","volume":"5","author":"Jerschow","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.04.013_bib140","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.jaci.2023.06.028","article-title":"Lower serum 15-HETE level predicts nasal ILC2 accumulation during COX-1 inhibition in AERD","volume":"152","author":"Badrani","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib141","doi-asserted-by":"crossref","first-page":"174ra26","DOI":"10.1126\/scitranslmed.3004812","article-title":"Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma","volume":"5","author":"Barnig","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib142","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jaci.2013.12.1086","article-title":"Allergen challenge in allergic rhinitis rapidly induces increased peripheral blood type 2 innate lymphoid cells that express CD84","volume":"133","author":"Doherty","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib143","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1164\/rccm.201609-1846OC","article-title":"Mucosal type 2 innate lymphoid cells are a key component of the allergic response to aeroallergens","volume":"195","author":"Dhariwal","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2026.04.013_bib144","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.clim.2017.09.008","article-title":"Increased innate type 2 immune response in house dust mite-allergic patients with allergic rhinitis","volume":"183","author":"Zhong","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4168\/aair.2016.8.3.216","article-title":"Allergen-dependent differences in ILC2s frequencies in patients with allergic rhinitis","volume":"8","author":"Fan","year":"2016","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2026.04.013_bib146","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jaip.2021.02.013","article-title":"Innate and adaptive immunity: ILC2 and Th2 cells in upper and lower airway allergic diseases","volume":"9","author":"Scadding","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2026.04.013_bib147","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.jaci.2020.10.029","article-title":"IL-10-producing innate lymphoid cells increased in patients with house dust mite allergic rhinitis following immunotherapy","volume":"147","author":"Boonpiyathad","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib148","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jaci.2015.09.019","article-title":"IL-25 and CD4(+) TH2 cells enhance type 2 innate lymphoid cell-derived IL-13 production, which promotes IgE-mediated experimental food allergy","volume":"137","author":"Lee","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib149","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2016.02.030","article-title":"IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function","volume":"138","author":"Noval Rivas","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.04.013_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.157101","article-title":"Group 2 innate lymphoid cells (ILC2s) in childhood allergic diseases: a review of the mechanisms and therapeutic advances","volume":"198","author":"Zhang","year":"2026","journal-title":"Cytokine"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926002940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926002940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:34:10Z","timestamp":1783071250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926002940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0091674926002940"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.04.013","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Group 2 innate lymphoid cells: Where are we 15 years out?","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}